ARAF and urinary bladder cancer: Finally, the p38 MAPK pathway activator, anisomycin, was used to explore the mechanism of ARAF in cancer cells.<h4>Results</h4>Intersecting genes related to bladder cancer were identified from the GeneCards and CTD databases, and ARAF was enriched in the p38MAPK pathway.